JP2024504136A5 - - Google Patents
Info
- Publication number
- JP2024504136A5 JP2024504136A5 JP2023543460A JP2023543460A JP2024504136A5 JP 2024504136 A5 JP2024504136 A5 JP 2024504136A5 JP 2023543460 A JP2023543460 A JP 2023543460A JP 2023543460 A JP2023543460 A JP 2023543460A JP 2024504136 A5 JP2024504136 A5 JP 2024504136A5
- Authority
- JP
- Japan
- Prior art keywords
- alanine
- amino acid
- methionine
- glycine
- valine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021900114 | 2021-01-19 | ||
| AU2021900114A AU2021900114A0 (en) | 2021-01-19 | Novel bicyclic peptipes | |
| PCT/AU2022/050023 WO2022155704A1 (en) | 2021-01-19 | 2022-01-19 | Novel bicyclic peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024504136A JP2024504136A (ja) | 2024-01-30 |
| JP2024504136A5 true JP2024504136A5 (enExample) | 2025-01-27 |
Family
ID=82548163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543460A Pending JP2024504136A (ja) | 2021-01-19 | 2022-01-19 | 「新規な二環式ペプチド」 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240117005A1 (enExample) |
| EP (1) | EP4281486A4 (enExample) |
| JP (1) | JP2024504136A (enExample) |
| KR (1) | KR20230146025A (enExample) |
| CN (1) | CN117062842A (enExample) |
| AU (1) | AU2022209878A1 (enExample) |
| CA (1) | CA3208598A1 (enExample) |
| IL (1) | IL304545A (enExample) |
| WO (1) | WO2022155704A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023307414A1 (en) * | 2022-07-13 | 2025-02-27 | The Council Of The Queensland Institute Of Medical Research | Novel inhibitors of histone methyltransferase nuclear localisation |
| CN121108243A (zh) * | 2025-01-03 | 2025-12-12 | 中国药科大学 | 一种非核糖体多肽化合物及其合成基因簇bnp37和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1452868A2 (en) * | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| ES2767730T3 (es) * | 2015-04-30 | 2020-06-18 | Univ Kyoto | Método para predecir el efecto terapéutico del inhibidor PD-1/PD-L1 usando una anomalía en PD-L1(CD274) como índice |
| CA3001264A1 (en) * | 2015-10-30 | 2017-05-04 | Affibody Ab | Pd-l1 binding polypeptide |
| EP3559018A1 (en) * | 2016-12-23 | 2019-10-30 | Bicyclerd Limited | Peptide derivatives having novel linkage structures |
| US20200339691A1 (en) * | 2018-01-15 | 2020-10-29 | Epiaxis Therapeutics Pty Ltd | Proteinaceous molecules and uses therefor |
| JP2019189591A (ja) * | 2018-04-27 | 2019-10-31 | 日東電工株式会社 | ヒトｐｄ−ｌ１結合性ペプチド |
| WO2020128527A1 (en) * | 2018-12-21 | 2020-06-25 | Bicyclerd Limited | Bicyclic peptide ligands specific for pd-l1 |
-
2022
- 2022-01-19 KR KR1020237027582A patent/KR20230146025A/ko active Pending
- 2022-01-19 US US18/273,200 patent/US20240117005A1/en active Pending
- 2022-01-19 WO PCT/AU2022/050023 patent/WO2022155704A1/en not_active Ceased
- 2022-01-19 CA CA3208598A patent/CA3208598A1/en active Pending
- 2022-01-19 AU AU2022209878A patent/AU2022209878A1/en active Pending
- 2022-01-19 EP EP22741955.3A patent/EP4281486A4/en active Pending
- 2022-01-19 JP JP2023543460A patent/JP2024504136A/ja active Pending
- 2022-01-19 CN CN202280022296.XA patent/CN117062842A/zh active Pending
-
2023
- 2023-07-18 IL IL304545A patent/IL304545A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0477885B1 (en) | Parathyroid hormone derivatives | |
| JP2018171063A5 (enExample) | ||
| JP2014510518A5 (enExample) | ||
| US20110288011A1 (en) | Peptide therapeutic conjugates and uses thereof | |
| JP2011511753A5 (enExample) | ||
| RU2015143472A (ru) | Конъюгаты инсулин-инкретин | |
| JP2006514607A5 (enExample) | ||
| CA2489227A1 (en) | Hla-a24-restricted cancer antigen peptides | |
| JP2012530145A5 (enExample) | ||
| JP2014508510A5 (enExample) | ||
| NO20025153D0 (no) | FremgangsmÕter og sammensetninger for Õ svekke formering av HIV-1 | |
| HK1208040A1 (en) | Cell penetrating peptides to target eif4e | |
| JP2015504052A5 (enExample) | ||
| EP2605786A2 (en) | Therapeutic peptides | |
| JP2007535910A5 (enExample) | ||
| US9611297B1 (en) | Compositions and methods for the treatment of cast nephropathy and related conditions | |
| JP6647207B2 (ja) | ヘマグルチニン結合ペプチド | |
| JP2021506815A5 (enExample) | ||
| JP2025102922A (ja) | 新規ｌｒｐ１結合ペプチド | |
| EP0724593A1 (en) | Coiled-coil stem loop templates | |
| JP2013071904A (ja) | 抗インフルエンザウイルス活性を有するペプチド | |
| WO2007126111A1 (ja) | アミロイドβ線維化阻害ペプチド | |
| JP2010150253A (ja) | 肝癌を治療するための薬剤 | |
| JPH09157294A (ja) | 副甲状腺ホルモン誘導体 | |
| CN108884130B (zh) | 用于治疗溃疡性结肠炎的制剂和方法 |